DNA-encoded libraries (DELs) have become a mainstay of small-molecule discovery, enabling millions to billions of compounds to be screened in a single pooled affinity selection in which each small molecule is covalently linked to a unique DNA identifier. However, the chemistry available for their construction remains l...
Oliver J. Corrigan, Sarah L. Allinson, Jamie H. Docherty· RSC Medicinal Chemistry· 0 citations
The current ATM, ATR, DNA-PK, CHK1, CHK2 and WEE1 inhibitors that show the most promise as monotherapies and combination treatments in solid tumours are discussed, as well as the potential benefits of using TPD technology over small-molecule inhibitors.
Lauryn Buckley-Benbow, Antonia M. Rout, Andrew B. Fielding et al.· TARGETS· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.